Dr. Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr. Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groun… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Bradford (UK) | Masters Degree | Other | Not Specified |
| Universidade Federal do Rio Grande do Sul | Doctorate | Other | 1997 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Hospital De clinicas de Porto Alegre | Internal Medicine | 1999 |
| Residency - University of Miami - Jackson Memorial Hospital | Internal Medicine | 2003 |
| Fellowship - Jackson Memorial Hospital Division of Hematology/Oncology | Hematology/Oncology | 2006 |
Accepts New Patients: Yes
Gilberto Lopes, MD has not yet listed the medications that he commonly prescribes.
Gilberto Lopes, MD has not yet specified the insurance plans he accepts.
